Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Harmony Biosciences Holdings, Inc. | CHIEF FINANCIAL OFFICER | Restricted Stock Units | 90K | $3.6M | $40.03 | Sep 30, 2024 | Direct |
Harmony Biosciences Holdings, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 27.9K | $1.12M | $40.00 | Sep 30, 2024 | Direct |
Harmony Biosciences Holdings, Inc. | CHIEF FINANCIAL OFFICER | Stock Option | 74.3K | Jan 24, 2024 | Direct | ||
Passage BIO, Inc. | Director | Director Stock Option (right to buy) | 47.7K | May 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HRMY | Harmony Biosciences Holdings, Inc. | Sep 30, 2024 | 3 | -$1.28M | 4 | Oct 2, 2024 | CHIEF FINANCIAL OFFICER |
PASG | Passage BIO, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
HRMY | Harmony Biosciences Holdings, Inc. | Mar 29, 2024 | 3 | -$269K | 4 | Apr 2, 2024 | CHIEF FINANCIAL OFFICER |
HRMY | Harmony Biosciences Holdings, Inc. | Jan 24, 2024 | 2 | $0 | 4 | Jan 26, 2024 | CHIEF FINANCIAL OFFICER |
HRMY | Harmony Biosciences Holdings, Inc. | Oct 4, 2023 | 1 | $0 | 4 | Nov 8, 2023 | CHIEF FINANCIAL OFFICER |
PASG | Passage BIO, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
HRMY | Harmony Biosciences Holdings, Inc. | Mar 29, 2023 | 3 | -$514K | 4 | Mar 31, 2023 | CHIEF FINANCIAL OFFICER |
PASG | Passage BIO, Inc. | Dec 1, 2022 | 1 | -$5.96K | 4 | Dec 2, 2022 | Director |
PASG | Passage BIO, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
PASG | Passage BIO, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |